Belongs to

• Pediatrics, Department of

Types of Work

["2020"]

[[["Journal Articles",459],["Meeting Abstracts",249],["Conference Papers",14],["Book Sections",12],["Reviews",7],["Editorials",5],["Correspondences",2],["Books Whole",1]]]

[749]

Popular keywords

• article
• child
• controlled study
• female
• human
• humans
• monoclonal antibody
• neuroblastoma
• priority journal
• unclassified drug

Recent Works

1. RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition

   Journal Article

   Nunes, C.; Depestel, L.; Mus, L.; Keller, K. M.; Delhaye, L.; Louwagie, A.; Rishfi, M.; Whale, A.; Kara, N.; Andrews, S. R.; more...
   Science Advances (2022)

   Fulltext@MSK | Save
2. Biodistribution and radiation dosimetry of intraperitoneally administered (124)I-omburtamab in patients with desmoplastic small round cell tumors

   Journal Article

   Grkovski, M.; Modak, S.; Zanzonico, P. B.; Carrasquillo, J. A.; Larson, S. M.; Humm, J. L.; Pandit-Taskar, N.
   Journal of Nuclear Medicine (2022)

   Fulltext@MSK | Save
3. Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers

   Journal Article

   Shukla, N.; Levine, M. F.; Gundem, G.; Domenico, D.; Spitzer, B.; Bouvier, N.; Arango-Ossa, J. E.; Glodzik, D.; Medina-Martínez, J. S.; Bhanot, U.; more...
   Nature Communications (2022)

   Fulltext@MSK | Save